A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants

NCT07573462 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

2400

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumococcal Disease

Interventions

BIOLOGICAL: PG4
BIOLOGICAL: 20-valent pneumococcal conjugate vaccine (20vPnC)

Sponsor

Pfizer